BREANNA MACLEOD: Open Payments
NPI 1215712955 · HALFMOON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 13 payments from 10 companies in 2025. Trend: 2023 $386 · 2024 $892 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $58 |
| Lilly USA, LLC | 2 | $42 |
| Novo Nordisk Inc | 1 | $25 |
| Verona Pharma, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: QULIPTA, ZEPBOUND, Wegovy, UBRELVY, Ohtuvayre, REXULTI, Kerendia, SHINGRIX.
Industry payments across NY — which companies pay providers there.
